INS and metabolic dysfunction-associated steatotic liver disease: Supporting the DAG model of insulin resistance, in obese subjects with non-alcoholic fatty liver disease (NAFLD), hepatic DAG content negatively correlated with insulin-induced suppression of hepatic glucose production [58].